Blood Cancer 101: The Basics on Disease, Treatment and the Role of the HCP

Instructions for Credit - There is no fee for this activity. To receive credit for this CE activity, review the accreditation and disclosure information, view the presentation in its entirety, successfully complete the post-activity assessment and evaluation. If you do not achieve a minimum score of 70% on the post-activity assessment, you will be allowed to take it again. This course is accredited for 1.5 continuing education credits. Please retain a copy of the certificate for your records.

Target Audience:
Oncology social workers, nurses, and other healthcare professionals involved in the care of patients with hematologic malignancies. Course content level for social workers: beginner and intermediate

Learning Objectives:
At the conclusion of this program, participants will be able to:

Describe the different blood cancers, including diagnosis and treatment
Describe the psychosocial impact of a blood cancer diagnosis
Explain the role of the social worker, nurse and other members of the healthcare team
Educate patients and caregivers about clinical trial participation
List resources for patients with blood cancers and how to access them

Speakers:
Laura Romundstad, MSN, RN, CRNP, AOCNP
Clinical Trial Nurse Navigator
Clinical Trial Support Center
The Leukemia & Lymphoma Society
Rye Brook, NY

Lynn Steele, LSW, OSW-C
Information Specialist
Information Resource Center
The Leukemia & Lymphoma Society
Rye Brook, NY

Continuing Education Information:
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.

Social Work Credit Designation
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.5 clinical continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.5 clinical CE contact hours for this activity.

Participants must review the webcast in its entirety and complete the evaluation and pass the post-test to obtain CE credit. After completing this process you will receive your certificate by email.

All continuing education credits are provided free of charge.

Disclosure of Conflicts of Interest:
Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker's bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by The Leukemia & Lymphoma Society for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Providers:
The associates of The Leukemia & Lymphoma Society, the accredited providers for this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE activity during the past 12 months.

Faculty Disclosures:
Laura Romundstad, MSN, RN, CRNP, AOCNP has no affiliations to disclose.
Lynn Steele, LSW, OSW-C has no affiliations to disclose.

Disclaimer - The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.

Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred.

Provider: The Leukemia & Lymphoma Society
Estimated time to complete activity: 1.5 hours
Date of initial release: January 6, 2023
Valid for CE credit through: July 6, 2024

For questions, concerns, or for assistance for people with disabilities or grievances, please contact ProfEducation@LLS.org


Instructions for Credit - There is no fee for this activity. To receive credit for this CE activity, review the accreditation and disclosure information, view the presentation in its entirety, successfully complete the post-activity assessment and evaluation. If you do not achieve a minimum score of 70% on the post-activity assessment, you will be allowed to take it again. This course is accredited for 1.5 continuing education credits. Please retain a copy of the certificate for your records. Target Audience: Oncology social workers, nurses, and other healthcare professionals involved in the care of patients with hematologic malignancies. Course content level for social workers: beginner and intermediate Learning Objectives: At the conclusion of this program, participants will be able to: Describe the different blood cancers, including diagnosis and treatment Describe the psychosocial impact of a blood cancer diagnosis Explain the role of the social worker, nurse and other members of the healthcare team Educate patients and caregivers about clinical trial participation List resources for patients with blood cancers and how to access them Speakers: Laura Romundstad, MSN, RN, CRNP, AOCNP Clinical Trial Nurse Navigator Clinical Trial Support Center The Leukemia & Lymphoma Society Rye Brook, NY Lynn Steele, LSW, OSW-C Information Specialist Information Resource Center The Leukemia & Lymphoma Society Rye Brook, NY Continuing Education Information: Registered Nursing Credit Designation Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing. Social Work Credit Designation The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.5 clinical continuing education credits. The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.5 clinical CE contact hours for this activity. Participants must review the webcast in its entirety and complete the evaluation and pass the post-test to obtain CE credit. After completing this process you will receive your certificate by email. All continuing education credits are provided free of charge. Disclosure of Conflicts of Interest: Before the activity, all faculty and anyone who is in a position to have control over the content of this activity and their spouse/life partner will disclose the existence of any financial interest and/or relationship(s) they might have with any commercial interest producing healthcare goods/services to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker's bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions. All identified conflicts of interest are thoroughly vetted by The Leukemia & Lymphoma Society for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Providers: The associates of The Leukemia & Lymphoma Society, the accredited providers for this activity, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE activity during the past 12 months. Faculty Disclosures: Laura Romundstad, MSN, RN, CRNP, AOCNP has no affiliations to disclose. Lynn Steele, LSW, OSW-C has no affiliations to disclose. Disclaimer - The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition. Recommendations for the use of particular therapeutic agents are based on the best available scientific evidence and current clinical guidelines. No bias towards or promotion for any agent discussed in this program should be inferred. Provider: The Leukemia & Lymphoma Society Estimated time to complete activity: 1.5 hours Date of initial release: January 6, 2023 Valid for CE credit through: July 6, 2024 For questions, concerns, or for assistance for people with disabilities or grievances, please contact ProfEducation@LLS.org